Effect of IL-2 therapy on plasma hepatitis C virus-RNA levels in HIV/hepatitis C virus co-infected patients.
Valdez
H
H
Metcalf
J A
JA
Gripshover
B M
BM
Jacobson
J M
JM
Mitsuyasu
R
R
Lederman
M M
MM
D017088:AIDS-Related Opportunistic Infections / Q000097:blood / Q000188:drug therapy / Q000821:virology*; D000410:Alanine Transaminase / Q000097:blood; D018791:CD4 Lymphocyte Count; D015497:HIV-1 / Q000235:genetics; D016174:Hepacivirus / Q000235:genetics; D006526:Hepatitis C / Q000097:blood / Q000188:drug therapy / Q000821:virology*; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage / Q000627:therapeutic use*; D012367:RNA, Viral / Q000097:blood*; D019562:Viral Load
D007376:Interleukin-2; D012367:RNA, Viral; D000410:Alanine Transaminase